Becton, Dickinson & Co. Stock
Price
Target price
€158.50
€158.50
0.700%
1.1
0.700%
€178.96
14.08.26 / Tradegate
WKN: 857675 / Symbol: BDX / Name: BD / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Becton, Dickinson & Co. Stock
The Becton, Dickinson & Co. stock is trending slightly upwards today, with an increase of €1.10 (0.700%) compared to yesterday's price.
With 13 Buy predictions and not the single Sell prediction the community is currently very high on Becton, Dickinson & Co..
With a target price of 178 € there is a slightly positive potential of 12.3% for Becton, Dickinson & Co. compared to the current price of 158.5 €.
Pros and Cons of Becton, Dickinson & Co. in the next few years
Pros
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Becton, Dickinson & Co. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Becton, Dickinson & Co. | 0.700% | 3.629% | 20.121% | -5.345% | -4.662% | -38.921% | -24.271% |
| Dexcom Inc. | -2.520% | 5.722% | 19.385% | 13.021% | 35.380% | -26.917% | -25.510% |
| Baxter International | -1.960% | -3.023% | 21.006% | 10.131% | 41.787% | -41.221% | -63.461% |
| Idexx Laboratories Inc. | -3.270% | -6.225% | 0.528% | -15.182% | -18.577% | 2.234% | -16.403% |
Comments
Becton, Dickinson and Company (BDX) had its "buy" rating reaffirmed by Citigroup Inc..
Show more
Ratings data for BDX provided by MarketBeat
Becton, Dickinson and Company (BDX) had its price target raised by Citigroup Inc. from $198.00 to $204.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BDX provided by MarketBeat
Becton, Dickinson and Company (BDX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Show more
Ratings data for BDX provided by MarketBeat
News
Becton, Dickinson and Company Q3 Earnings Call Highlights
Key Points
- Interested in Becton, Dickinson and Company? Here are five stocks we like better.
- Strong Q3 performance: Becton, Dickinson and Company reported $5 billion in fiscal 2026
Becton, Dickinson and Company Q2 Earnings Call Highlights
Becton, Dickinson and Company (NYSE:BDX) reported fiscal second-quarter revenue and adjusted earnings ahead of its internal
The Healthcare Stock Built for Investors Who Prioritize Capital Preservation
Wanting to invest in healthcare is a savvy instinct. It is, after all, a major expense in America. Per the Peterson-KFF Health System Tracker, "On a per capita basis, total health spending
